From Treatment Advocacy Center <[email protected]>
Subject Petition to support efforts to end the FDA’s regulatory barriers to Clozapine for SMI!
Date October 14, 2024 8:01 PM
  Links have been removed from this email. Learn more in the FAQ.
Screenshot of the email generated on import

Message Analysis